Cellect Biotechnology LTd.

25.07.2016 | NASDAQ

ZAG-S&W Team represented Cellect Biotechnology Ltd. in its IPO on NASDAQ

A ZAG-S&W Team represented Cellect Biotechnology Ltd. in its initial public offering in the United States of 1,292,308 American Depository Shares (ADSs) and warrants to purchase up to 969,231 ADSs.

The gross proceeds to Cellect from this offering are $8.4 million.

 

Recent Activity